Literature DB >> 30661128

Obesity in Adolescents with Psychiatric Disorders.

Ariana M Chao1,2, Thomas A Wadden2, Robert I Berkowitz3,4.   

Abstract

PURPOSE OF REVIEW: This narrative review synthesized recent research related to obesity in adolescents with psychiatric disorders, with a focus on epidemiology, mechanisms, and weight management approaches. The paper reviews literature on depressive and anxiety disorders, bipolar disorder, and schizophrenia spectrum and other psychotic disorders. RECENT
FINDINGS: Depression has a bidirectional relationship with obesity. Bipolar disorder and schizophrenia spectrum disorders, and their treatments, increase the risk of developing obesity. Mechanisms underlying this weight gain include lifestyle and environmental factors and psychiatric medications, though emerging evidence has also suggested the role of genetic and neuroendocrine processes. Evidence about the most effective treatments for obesity in adolescents with psychiatric disorders remains limited. Adolescents with psychiatric disorders are at high risk for obesity. Close monitoring for increases in weight and cardiometabolic risk factors with use of antipsychotic and mood-stabilizing medications is recommended. Clinical trials are needed that test the efficacy of weight management strategies for this population.

Entities:  

Keywords:  Adolescence; Bipolar disorder; Depression; Obesity; Psychiatric disorders; Schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 30661128      PMCID: PMC6529197          DOI: 10.1007/s11920-019-0990-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  94 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

Authors:  Chen Hu; Ivan J Torres; Hong Qian; Hubert Wong; Priyanka Halli; Taj Dhanoa; Sharon Ahn; Gang Wang; David J Bond; Raymond W Lam; Lakshmi N Yatham
Journal:  J Affect Disord       Date:  2016-10-11       Impact factor: 4.839

3.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

4.  A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis.

Authors:  Scott B Teasdale; Philip B Ward; Simon Rosenbaum; Andrew Watkins; Jackie Curtis; Megan Kalucy; Katherine Samaras
Journal:  Br J Nutr       Date:  2016-06       Impact factor: 3.718

5.  Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors:  Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

Review 6.  Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Authors:  Christoph U Correll; Stefan Leucht; John M Kane
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

Review 7.  Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Authors:  Sabina Abidi; Irfan Mian; Iliana Garcia-Ortega; Tania Lecomte; Thomas Raedler; Kevin Jackson; Kim Jackson; Tamara Pringsheim; Donald Addington
Journal:  Can J Psychiatry       Date:  2017-08-02       Impact factor: 4.356

8.  Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations.

Authors:  Yuri Milaneschi; Femke Lamers; Wouter J Peyrot; Bernhard T Baune; Gerome Breen; Abbas Dehghan; Andreas J Forstner; Hans J Grabe; Georg Homuth; Carol Kan; Cathryn Lewis; Niamh Mullins; Matthias Nauck; Giorgio Pistis; Martin Preisig; Margarita Rivera; Marcella Rietschel; Fabian Streit; Jana Strohmaier; Alexander Teumer; Sandra Van der Auwera; Naomi R Wray; Dorret I Boomsma; Brenda W J H Penninx
Journal:  JAMA Psychiatry       Date:  2017-12-01       Impact factor: 21.596

9.  Obesity and depression in adolescence and beyond: reciprocal risks.

Authors:  N R Marmorstein; W G Iacono; L Legrand
Journal:  Int J Obes (Lond)       Date:  2014-01-31       Impact factor: 5.095

Review 10.  Psychosocial status and mental health in adolescents before and after bariatric surgery: a systematic literature review.

Authors:  Sabine Herget; Almut Rudolph; Anja Hilbert; Susann Blüher
Journal:  Obes Facts       Date:  2014-07-24       Impact factor: 3.942

View more
  13 in total

Review 1.  Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation.

Authors:  Qin Zhang; Kangyu Jin; Bing Chen; Ripeng Liu; Shangping Cheng; Yuyan Zhang; Jing Lu
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

2.  Overweight and obesity are associated with increased eating disorder correlates and general psychopathology in university women with eating disorders.

Authors:  Katherine N Balantekin; Anne Claire Grammer; Ellen E Fitzsimmons-Craft; Dawn E Eichen; Andrea K Graham; Grace E Monterubio; Marie-Laure Firebaugh; Anna M Karam; Shiri Sadeh-Sharvit; Neha J Goel; Rachael E Flatt; Mickey T Trockel; C Barr Taylor; Denise E Wilfley
Journal:  Eat Behav       Date:  2021-02-13

3.  Attention deficit hyperactivity disorder medications and BMI trajectories: The role of medication type, sex and age.

Authors:  Matthew J Gurka; Siraj U Siddiqi; Stephanie L Filipp; Rebeccah Mercado; Lindsay A Thompson; David M Janicke; Elizabeth A Shenkman
Journal:  Pediatr Obes       Date:  2020-10-16       Impact factor: 4.000

4.  Body composition in Japanese patients with psychiatric disorders: A cross-sectional study.

Authors:  Taro Kishi; Makoto Okuya; Kenji Sakuma; Yohei Otaka; Eiichi Saitoh; Nakao Iwata
Journal:  Neuropsychopharmacol Rep       Date:  2021-01-28

5.  Biobehavioural approaches to prevention and treatment: A call for implementation science in obesity research.

Authors:  Kathryn A Kaiser; Tiffany L Carson; Emily J Dhurandhar; William H Neumeier; Michelle I Cardel
Journal:  Obes Sci Pract       Date:  2020-01-22

6.  Prevalence and associated factors of overweight/obesity among severely ill psychiatric patients in Eastern Ethiopia: A comparative cross-sectional study.

Authors:  Dilnessa Fentie; Tariku Derese
Journal:  PLoS One       Date:  2022-03-02       Impact factor: 3.240

7.  Effect of adenotonsillectomy in children with obstructive sleep apnea and major psychiatric disorders on obstructive apnea-hypopnea index and Epworth Sleepiness Scale scores.

Authors:  Melissa Scholes; Emily Jensen; Maxene Meier; Norman Friedman
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

8.  Obesity, Migraine, and Overlapping Comorbidities in a Rural Pediatric Population.

Authors:  Suzy M Walter; Zheng Dai; Kesheng Wang
Journal:  J Neurosci Rural Pract       Date:  2021-05-10

9.  Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI.

Authors:  Claudia Pisanu; Michael J Williams; Diana M Ciuculete; Gaia Olivo; Maria Del Zompo; Alessio Squassina; Helgi B Schiöth
Journal:  Transl Psychiatry       Date:  2019-11-21       Impact factor: 6.222

10.  The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis.

Authors:  Jianbo Yu; Xufeng Liao; Yanzi Zhong; Yongqiang Wu; Xinsheng Lai; Huifeng Jiao; Min Yan; Yu Zhang; Chaolin Ma; Shunqi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.